Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2022 16:05 ET | Source: Societal CDMO, Inc.

Societal CDMO to Report Financial Results for First Quarter 2022 on May 11, 2022

SAN DIEGO and GAINESVILLE, Ga., May 04, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
April 27, 2022 07:00 ET | Source: Societal CDMO, Inc.

Societal CDMO Secures Manufacturing and Packaging Task Order Award from National Cancer Institute (NCI)

SAN DIEGO and GAINESVILLE, Ga., April 27, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
April 06, 2022 16:05 ET | Source: Societal CDMO, Inc.

Societal CDMO Reports Inducement Grants for New Staff

SAN DIEGO and GAINESVILLE, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASD: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
March 21, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation

With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers’ Goal of Delivering Impactful Medicines to SocietyNew...
March 01, 2022 16:05 ET | Source: Recro Pharma, Inc.

Recro Reports Fourth Quarter and Year End 2021 Financial Results

Recorded Q4 Revenue of $22.3 Million; Full Year Revenue of $75.4 Million More than Tripled Customer Base in 2021; Significantly Diversified Clientele Grew Organic New Business by 63% in 2021; Grew...
February 23, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego Facility

SAN DIEGO, Calif. and GAINESVILLE, Ga., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to...
February 22, 2022 16:05 ET | Source: Recro Pharma, Inc.

Recro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022

SAN DIEGO and GAINESVILLE, Ga., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASDAQ: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving...
January 26, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer Prevention

SAN DIEGO, and GAINESVILLE, Ga., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
January 19, 2022 07:00 ET | Source: Recro Pharma, Inc.

Recro Appoints Eduardo Uribe as Head of Quality for Recro San Diego

SAN DIEGO and GAINESVILLE, Ga., Jan. 19, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
January 06, 2022 16:05 ET | Source: Recro Pharma, Inc.

Recro Reports Inducement Grants For New Staff

SAN DIEGO, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right